Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO

Ранг среди акций #2157
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Цена акции
$354.75
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$9.49B
Изменение (1 день)
0.76%
Изменение (1 год)
7.09%
Страна
US
Торговля Bio-Rad Laboratories, Inc. (BIO)

Категория

Healthcare
Выручка компании Bio-Rad Laboratories, Inc. (BIO)
Выручка на Jun 2026 TTM: $2.59B
Согласно последним финансовым отчетам Bio-Rad Laboratories, Inc., текущая выручка компании (TTM) составляет $2.59B. В 2024 году компания получила выручку $2.57B меньше, чем выручке в 2023 году, которая составила $2.67B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Bio-Rad Laboratories, Inc. с 2000 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $2.59B 0.24%
2025 $2.58B 0.65%
2024 $2.57B -3.92%
2023 $2.67B -4.67%
2022 $2.80B -4.12%
2021 $2.92B 14.81%
2020 $2.55B 10.12%
2019 $2.31B 0.94%
2018 $2.29B 6.02%
2017 $2.16B 4.45%
2016 $2.07B 2.41%
2015 $2.02B -7.15%
2014 $2.18B 1.99%
2013 $2.13B 3.07%
2012 $2.07B -0.21%
2011 $2.07B 7.60%
2010 $1.93B 8.01%
2009 $1.78B 1.13%
2008 $1.76B 20.76%
2007 $1.46B 14.69%
2006 $1.27B 7.87%
2005 $1.18B 8.35%
2004 $1.09B 8.63%
2003 $1.00B 12.40%
2002 $892.72M 9.20%
2001 $817.51M 12.62%
2000 $725.88M 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
$46.59B 1,699.13%
US
$35.48B 1,270.41%
IE
$25.84B 897.84%
US
$21.00B 710.88%
US
- -
DE